Patient safety and public health concerns: poor dissolution rate of pioglitazone tablets obtained from China, Myanmar and internet sites

Table 4 Summary of the results of laboratory analysis

Sampling Site	Year	Test	Test (n/%)
			Originator Brand		Generic		Total samples, n
			Compliant	Non-compliant	Compliant	Non-compliant	Total samples, n
China (Shanghai)	2012	Potency	9/100	0/0	34/97	1/3	44
		Content Uniformity	9/100	0/0	35/100	0/0
		Dissolution	9/100	0/0	35/100	0/0
Personal import samples	2013	Potency	19/100	0/0	13/100^a	13/100^a	59
		Content Uniformity	19/100	0/0	13/100^a	13/100^a
		Dissolution	19/100	0/0	8/62^a	5/38^a
Yangon, Myanmar	2015	Potency	1/100	0/0	59/98	1/2	60
		Content Uniformity	1/100	0/0	59/98	1/2
		Dissolution	1/100	0/0	51/86	8/14
Total number of samples, n			163

^aAmong the n = 31 generic samples, only 13 samples could be fully tested, as the number of tablets was insufficient

ISSN: 2050-6511